HHS Waives Enforcement For Six Peptides
Pharmacies may compound six unapproved peptides during HHS review despite FDA scientists' objections.
October 29, 2026 · Updated Oct 29, 5:01pm ET
CNNPeptides could soon be easier to get in the United States. Here’s what to know
USA TODAYUS Health Secretary RFK Jr. opens access to some unapproved peptides
New York PostTrump admin eases access to unproven peptides favored by RFK Jr. despite FDA opposition
Daily KosRFK Jr. may hate vaccines, but he loves mystery shots
UPIRFK Jr. to allow use of unapproved peptide injections, bypassing FDA rules
ABC NewsSome wellness peptides will become widely available, HHS says
BBC NewsUS Health Secretary RFK Jr to expand access to unapproved peptides
STAT NewsHHS green lights six peptides, despite concerns from FDA scientists
NPRTrump administration will allow pharmacies to make popular peptides
CBS NewsRFK Jr. to ease access to unapproved peptides, draft policy states
ReasonRFJ Jr. institutes backdoor approval of 6 peptides
18%
Left · 2
73%
Center · 8
9%
Right · 1
Pano rates the coverage Mostly Center.
What happened
HHSDepartment of Health and Human ServicesUnited States federal executive department Secretary Robert F. Kennedy Jr.
Robert F. Kennedy Jr.26th United States Secretary of Health and Human Services since 2025 issued a draft policy directing the FDA not to take enforcement action against qualifying pharmacies and physicians compounding six unapproved peptides. The move eases access without formally approving the drugs. The peptides lack FDA approval, and human trial evidence has not established their safety and effectiveness. HHS said some consumers had turned to gray-market products from sources with uncertain ingredient quality. An FDA advisory panel recommended allowing the six peptides in compounding, while FDA staff scientists opposed loosening restrictions. HHS said compounders must use patient-specific prescriptions, traceable ingredients, quality testing and safety reporting. The draft policy faces a two-week public comment period.
How the left told it
Left-leaning outlets framed the move as a clash between wellness access and missing proof, with sharper attention to scientific doubts than to patient choice. CNN stressed that the peptides had not met FDA standards for safety, quality and effectiveness, while noting the gray-market risk of unsupervised use. Daily Kos cast Kennedy as favoring “mystery shots” despite his vaccine stance.
How the right told it
Only one right-leaning outlet we track covered this: New York Post, under the headline “Trump admin eases access to unproven peptides favored by RFK Jr. despite FDA opposition”.
HHS Peptide Compounding Policy
Part of the storyline · Storyline →- Oct 29HHS Waives Enforcement For Six Peptides (this story)Mostly Center
- Oct 28HHS Allows Unapproved PeptidesMostly Left
